Tobacco Research at NIDA: Neuroscience, Treatment and Regulatory-related studies
|
|
- Letitia Terry
- 6 years ago
- Views:
Transcription
1 % of Basal Release Dopamine (nm) Wilson M. Compton, MD, MPE Deputy Director, National Institute on Drug Abuse Tobacco Research at NIDA: Neuroscience, Treatment and Regulatory-related studies Themes for NIDA Research Basic Research Genetics (understanding impact of genetics on vulnerability to smoking-related morbidity/mortality) Biomarkers of vulnerability Prevention Research (ABCD) Medications Development Behavioral and Integrated Treatments Vulnerable Populations (e.g., pregnant women, mental illness) Integrated Tobacco Epidemiology (MTF, PATH) All Drugs Abused by Humans Raise Brain Dopamine Levels in the Nucleus Accumbens ` METHAMPHETAMINE Dose (mg/kg IV) min Time After Methamphetamine NICOTINE hr Time After Nicotine Di Chiara et al. Nestler, Nature Neurosci,
2 Habenula and Negative Reward HABENULA Habenula neurons increased firing for NO REWARD and decreased firing for REWARD Dopamine neurons increased firing for REWARD and decreased firing for NO REWARD. Kimura et al., Nature Neuroscience Habenula inhibits dopamine neurons Habenula communicates negative reward signals to dopamine neurons Convergent Results Support CHRNA5/A3/B4 Gene Cluster Association with Nicotine Dependence a5, a3, 4, have a high concentration in habenula and interpeduncular nucleus Biological Psychiatry Medial habenula Genes Affect Risk for Smoking Progression, Odds of Quitting and Whether Medications May Help *Belsky DW, et al., JAMA Psychiatry 70: , 2013 *Chen LS et al., Am J Psychiatry 169: , 2012 *Chen LS et al., Addiction 109: ,
3 Mental Disorder Comorbid Disorders Addictive Disorder COMORBIDITY In the USA 44% Cigarettes Consumed by the Mentally Ill Lasser et al., JAMA 2011 Smoking Rates Normal Population: 23%* Alcoholism: 56.1% (past mo.); 43.5% (lifetime)** Drug Addictions: 67.9% (past mo.); 49% (lifetime)** Schizophrenia: 70-85%*** Depression: 44.7% (past mo.); 36.6% (lifetime)** Anxiety: 54.6% (past mo.); 46% (lifetime)** PTSD: 44.6% (past mo.); 45.3% (lifetime)** ADHD: 41-42% (adults)**** 19-46% (adolescents)**** *2010 National Survey on Drug Use and Health, SAMHSA **Lasser et al.,jama 2000; 284(20): ***Ziedonis et al., Nic and Tob Res 2008;10(12): ****McLernon et al., Ann NY AcadSci 2008;1141: People with Severe Mental Illness Much More Likely to Use Tobacco and Other Drugs >4 Drinks Alcohol/Day Daily Smoking > 1 mo Individuals with SMI were 4X more likely to be heavy alcohol users and almost 4X more likely to be regular marijuana users Protective factors usually associated with lower rates of substance use did not carry over to this population Marijuana > 21x/year Other Drugs > 10x *Hartz SM, et al., JAMA Psychiatry, 7: , 2014 Past Month Cigarette Use and Nicotine Dependence among Persons Aged 12 or Older, by Past Year Substance Use Treatment: 2005 to 2009 The NSDUH Report: Nicotine Dependence among Persons Who Received Substance Use Treatment, SAMHSA
4 Use of Mentholated Cigarette May Play Role in Cocaine Dependence and Abstinence Smoking cessation treatment can improve quit rates in individuals also undergoing concurrent treatment for stimulant addiction, However, use of menthol cigarettes may complicate cocaine treatment outcomes for cocaine-dependent individuals Stimulant Abstinence as a function of stimulantdependent diagnosis and cigarette type *Winhusen TM et al., J Clin Psychiatry 75: , 2014 *Winhusen TM et al., Drug and Alcohol Dependence 133: , 2013 Maintenance pharmacotherapy+ CBT can help individuals with SMI stay smoke-free Maintenance pharmacotherapy with varenicline and cognitive behavioral therapy improved prolonged tobacco abstinence rates for individuals with serious mental illness after 1 year of treatment and at 6 months after treatment discontinuation *Evins et al., Maintenance Treatment with Varenicline for Smoking Cessation in Patients with SCZ and Bipolar Disorder, JAMA 311: , 2014 Smoking Cessation Treatment During Psychiatric Hospitalization Reduces Smoking Rates & Improves Mental Health *Prochaska, Hall, et al., Efficacy of Initiating Tobacco Dependence Treatment in Inpatient Psychiatry: A Randomized Controlled Trial, American Journal of Public Health, 104: ,
5 Electronic Nicotine Delivery Systems: Promise or Peril? Promise: If governments, parliaments, regulation agencies, and experts are able to restrain their yearning to restrict access to e-cigarettes, these products are likely to represent a revolution in public health. Etter, Peril: Urged on by myopic health professionals who seem to have lost any population health focus they might have had, this may become one of the biggest blunders of modern public health. Chapman, Middle ground: [our responses to ECIGs] will provide the greatest public health benefit when they are proportional, based on evidence, and incorporate a rational appraisal of likely risks and benefits. Hajek et al., in press. Slide Courtesy of Thomas Eissenberg, Virginia Commenwealth University, USA More Youth in USA Using E-Cigarettes Than Tobacco Cigs Past Month Use of E-Cigs vs. Traditional Cigarettes in the 2014 Monitoring the Future Study of 8 th, 10 th and 12 th Grade Students in USA % 16.2% % % Tobacco Cigarettes 8 7.2% E-Cigarettes th Grade 10th Grade 12th Grade Monitoring the Future Study, University of Michigan Large Numbers of Youth in USA Using E-Cigarettes Without Prior Use of Tobacco Past Month Use of E-Cigarettes Among Youth with/without Any Lifetime Use of Tobacco Cigarettes or Smokeless Tobacco in the 2014 Monitoring the Future Study of 8 th, 10 th and 12 th Grade Students in USA % 3 21% E-Cigs Only E-Cigs and Any Lifetime Tobacco 8th Grade 10th Grade 12th Grade Monitoring the Future Study, University of Michigan 5
6 Adolescent Brain Cognitive Development National Longitudinal Study NIDA, NIAAA, NCI, NICHD, NIMHD, ORWH, NIMH, NINDS, OBSSR Ten year longitudinal study of 10,000 children from age 10 to 20 years to assess effects of drugs on individual brain development trajectories Population Assessment of Tobacco and Health (PATH) Study National, longitudinal cohort study of 45,000+ users of tobacco products and those at risk for tobacco use ages 12 and older in the U.S. Funded by the Center for Tobacco Products, FDA. Results from this study will inform the impact of FDA regulatory authority over tobacco products, and help to inform future activities. Contract Award 1 Field Test Baseline Wave 2 Wave Today PATH Study Domains (examples) Baseline Sample 45,971 total (32,320 age 18+, 13,651 age 12-17) Outcomes Tobacco Product Use including Dual Use, Switching, New Products Tobacco Use Behaviors including Initiation, Cessation/Quitting, Relapse Health Outcomes Mediators/Moderators Demographics Knowledge, Attitudes, Beliefs, and Risk Perceptions Tobacco Addiction Peer, Environmental, Contextual influences Mental Health/Substance Abuse Co-morbidities 6
7 Youth Past 12 Month Alcohol, Blunt, and Marijuana Use Prevalence* By Past 30 Day Tobacco Use Alcohol Use Past 12 Months (n=1023) Blunt Use Past 12 Months (n=337) Any Marijuana Use Past 12 Months (n=596) 4 2 Population Any Tobacco Cigarettes E-cigarettes Cigarillos Hookah Smokeless, Traditional Use excl snus cigars Filtered cigars Pipe Snus * Current use for each tobacco product is use in the past 30 days. Past year alcohol use is defined as using any alcohol in the past 12 months. Blunt use is report of having smoked all or part of a cigar with marijuana in it in the past 12 months. Any Marijuana use is blunt use or report of having used marijuana, hash, THC, grass, pot or weed in the past 12 months. Youth Past 12 Month Internalizing Severity* By Past 30 Day Tobacco Use Low (n=2852) 8 6 Moderate (n=1759) High (n=1421) 4 2 Population Any Cigarettes E-cigarettes Cigarillos Hookah Smokeless, Traditional Tobacco Use Excl snus cigars Filtered cigars Pipe Snus *Includes significant problems during the past year with: feeling very trapped/sad/depressed; trouble sleeping; feeling nervous/anxious/tense/scared; being distressed/upset about the past. Severity indicates the report of 0-1 problems (Low), 2-3 (Moderate), or 4 (High). Youth Past 12 Month Externalizing Severity* By Past 30 Day Tobacco Use Low (n=2927) 8 Moderate (N=2492) 6 High (n=573) 4 2 Population Any Cigarettes E-cigarettes Cigarillos Hookah Smokeless, Traditional Filtered Pipe Snus Tobacco Excl snus cigars cigars Use *Include two or more occurrences in the past year of: hard time paying attention/following instructions; lied/ conned to get something; bullied/threatened people; started a physical fight. Severity indicates the report of 0-1 (Low), 2-3 (Moderate), 4-5 (High). 7
8 Adult Past 12 Month Alcohol, Blunt, and Marijuana Use Prevalence* By Current Tobacco Use* 10 Alcohol Use Past 12 Months (n=10050) Blunt Use Past 12 Months (n=1770) Any Marijuana Use Past 12 Months (n=3002) * Current cigarette use is 100 lifetime and currently use everyday or some days; other tobacco products currently use everyday or some days. Past year alcohol = any in past 12 mos. Blunt = smoked all or part of a cigar with MJ in past 12 mos. Any Marijuana = blunt or MJ, hash, THC, grass, pot or weed in past 12 mos. Adult Past 12 Month Internalizing Severity By Current Tobacco Use 8 Low (n=8486) Moderate (n=3405) High (n=2452) Adult Past 12 Month Externalizing Severity By Current Tobacco Use Low (n=10407) Moderate (N=3458) High (n=410)
9 PATH Next Steps Data collection ongoing Selected analysis ongoing Accelerated efforts to have the PATH Study be a resource to the scientific community while ensuring highest data quality More Information: PATHstudyinfo.nih.gov Themes for NIDA Research Basic Research Genetics (understanding impact of genetics on vulnerability to smoking-related morbidity/mortality) Biomarkers of vulnerability Prevention Research (ABCD) Medications Development Behavioral and Integrated Treatments Vulnerable Populations (e.g., pregnant women, mental illness) Integrated Tobacco Epidemiology (MTF, PATH) 9
FDA Center for Tobacco Products: Tobacco Research and the Population Assessment of Tobacco and Health (PATH) Study
FDA Center for Tobacco Products: Tobacco Research and the Population Assessment of Tobacco and Health (PATH) Study Regulatory Public Laws Compliance & Education Policies Science & Enforcement & Communications
More informationNIDA Director s Report to the National Advisory Councils of NIDA, NIAAA, & NCI February 4, Nora D. Volkow, M.D., Director
NIDA Director s Report to the National Advisory Councils of NIDA, NIAAA, & NCI February 4, 2015 Nora D. Volkow, M.D., Director $ (in thousands) NIDA Program Level in Appropriated Dollars and Constant 1998
More informationNIDA/FDA Collaborations
NIDA/FDA Collaborations Wilson M. Compton, M.D., M.P.E. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse National Institutes of Health Tobacco use is
More information/msdcenter. msdcenter. Tomorrow in Austin and via Livestream: msdcenter.org
FYI Tomorrow in Austin and via Livestream: http://go.uth.edu/tcors2016 @msdcenter /msdcenter /msdcenter /msdcenter msdcenter.org msdcenter Emerging Trends in Tobacco and Other Substance Use In High School
More informationMarijuana Science Update
Marijuana Science Update Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse ADVANCING ADDICTION SCIENCE NIDA CANNABIS SCIENCE RESEARCH AREAS EPIDEMIOLOGY: National and Local
More informationChanging Federal Health Care Policies
Changing Federal Health Care Policies A view from NIDA Carlos Blanco, M.D., Ph.D. Director Division of Epidemiology, Services and Prevention National Institute on Drug Abuse Advancing Addiction Science
More informationUnderstanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO
Understanding Addiction and Its Impact on the Brain SDSMA Webinar Matthew Stanley, DO Estimated Economic Cost to Society Due to Substance Abuse and Addiction: Illegal drugs: Alcohol: Tobacco: $181 billion/year
More informationELECTRONIC CIGARETTES WHAT S THE BOTTOM LINE?
ELECTRONIC CIGARETTES WHAT S THE BOTTOM LINE? E-cigarettes have the potential to benefit adult smokers who are not pregnant if used as a complete substitute for regular cigarettes and other smoked tobacco
More information16851 Mount Wolfe Road Caledon ON L7E 3P or 1 (855)
2 Copyright 2015, Canadian Network for Respiratory Care 16851 Mount Wolfe Road Caledon ON L7E 3P6 905 880-1092 or 1 (855) 355-4672 www.cnrchome.net www.cnrchome.net Contents 1 Health Promotion and Tobacco
More informationPharmacological Treatments for Tobacco Users with Behavioral Health Conditions
Pharmacological Treatments for Tobacco Users with Behavioral Health Conditions Jill M Williams, MD Professor Psychiatry Director, Division Addiction Psychiatry Robert Wood Johnson Medical School Disclosures
More informationTobacco treatment for people with serious mental illness (SMI)
Tobacco treatment for people with serious mental illness (SMI) An opportunity to close the mortality gap Massachusetts Mental Health Center 1 National Resource Center for Academic Detailing A compelling
More informationTobacco Dependence Treatment From Neurobiology through Public Policy
Tobacco Dependence Treatment From Neurobiology through Public Policy Mary Ellen Wewers, PhD, MPH, RN Professor Emerita The Ohio State University College of Public Health Disclosures Funding from the National
More informationDisclosure 8/27/2014. Smoking and Substance Abuse in Individuals. ADHD and Drug Abuse
Smoking and Substance Abuse in Individuals with Brooke Molina, Ph.D. University of Pittsburgh Jessica Rhodes, Ph.D. University of Pittsburgh Disclosure Brooke Molina and Jessica Rhodes have no actual or
More informationCigarettes and Other Nicotine Products
Cigarettes and Other Nicotine Products Nicotine is one of the most heavily used addictive drugs in the United States. In 2002, 30 percent of the U.S. population 12 and older 71.5 million people used tobacco
More informationEffects of Marijuana On Brain, Body & Behavior. Nora D. Volkow, MD Director
Effects of Marijuana On Brain, Body & Behavior Nora D. Volkow, MD Director Marijuana is the Most Commonly Used Illicit Drug In the U.S. Over 111 million Americans have tried it at least once An estimated
More informationBASIC SKILLS FOR WORKING WITH SMOKERS
BASIC SKILLS FOR WORKING WITH SMOKERS Course Description Goals and Learning Objectives 55 Lave Ave No, Worcester, MA 01655 www.umassmed.edu/tobacco 2016 Basic Skills for Working with Smokers 1 Table of
More informationScience = Solutions. Carlos Blanco, M.D., Ph.D. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse
Advancing Addiction Science Science = Solutions Carlos Blanco, M.D., Ph.D. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse John Smith James Smith Ann
More informationPolicy Implications of the Neurobiology of Addiction
Policy Implications of the Neurobiology of Addiction Facilitator: Jay Butler, MD, President of ASTHO, Chief Medical Officer Alaska Department of Health and Social Services Director, Alaska Division of
More informationThe Neurobiology of Addiction
The Neurobiology of Addiction Jodi Gilman, Ph.D. Center for Addiction Medicine Massachusetts General Hospital Associate Professor, Department of Psychiatry Harvard Medical School What is Addiction? commonly
More informationVarenicline Update. Serena Tonstad, MD, PhD Dept of Preventive Cardiology Ullevål University Hospital Oslo, Norway
Varenicline Update Serena Tonstad, MD, PhD Dept of Preventive Cardiology Ullevål University Hospital Oslo, orway October 23, 2015 Disclosures related to smoking cessation: Pfizer, Mceil, ovartis Binding
More informationMarijuana is the Most Commonly Used Illicit Drug In the U.S.
Effects of Marijuana On Brain, Body & Behavior Marijuana is the Most Commonly Used Illicit Drug In the US Nora D Volkow, MD Director Over million Americans have tried it at least once An estimated million
More informationConcurrent Disorders
Concurrent Disorders Dr. Christy Sutherland MD CCFP dipabam Medical Director, PHS Community Services Methadone/Buprenorphine 101 Workshop April 1, 2017 Overview Introduction Epidemiology Treatment Principles
More information8. Attitudes and Beliefs
8. Attitudes and Beliefs Older adolescent Kentuckians are more likely to view smoking, alcohol use, and marijuana use positively than younger adolescents. Participants were asked if they thought they would
More informationBASIC SKILLS FOR WORKING WITH SMOKERS
BASIC SKILLS FOR WORKING WITH SMOKERS Course Description Goals and Learning Objectives 368 Plantation Street, Worcester, MA 01605 www.umassmed.edu/tobacco 2018 Basic Skills for Working with Smokers 1 Table
More informationInitiation of Smoking and Other Addictive Behaviors: Understanding the Process
Initiation of Smoking and Other Addictive Behaviors: Understanding the Process Carlo C. DiClemente, Ph.D. Director of MDQuit UMBC Presidential Research Professor Department of Psychology, UMBC diclemen@umbc.edu
More informationWHAT SHOULD WE KNOW ABOUT MARIJUANA
WHAT SHOULD WE KNOW ABOUT MARIJUANA Marijuana is the most commonly used illicit drug in the U.S. The use of marijuana can produce adverse physical, mental, emotional, and behavioral effects. What is marijuana?
More informationEffects of Marijuana On Brain, Body & Behavior. Nora D. Volkow, MD Director
Effects of Marijuana On Brain, Body & Behavior Nora D. Volkow, MD Director Marijuana is the Most Commonly Used Illicit Drug In the U.S. Over 111 million Americans have tried it at least once An estimated
More informationStrategies for Integrating Smoking Cessation & Wellness into Psychiatric & Substance Abuse Treatment Settings
Strategies for Integrating Smoking Cessation & Wellness into Psychiatric & Substance Abuse Treatment Settings Antoine Douaihy, MD Associate Professor of Psychiatry University of Pittsburgh School of Medicine
More informationCigarettes and Other Tobacco Products
Cigarettes and Other Tobacco Products Tobacco use is the leading preventable cause of disease, disability, and death in the United States. According to the Centers for Disease Control and Prevention (CDC),
More informationTobacco, alcohol, and opioid dependence
Tobacco, alcohol, and opioid dependence Sheila Duffy Chief Executive, ASH Scotland RCP Addictions Faculty meeting, Dunkeld 27 th February 2015 Alcohol and drugs in Scotland headline stats there were 1,100
More informationThe Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison
The Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison Attitudes about addiction and recovery throughout history Disease?
More information9/16/2016. I would feel comfortable dispensing/prescribing varenicline to a patient with a mental health disorder. Learning Objectives
The Smoking Gun: for Smoking Cessation in Patients with Mental Health Disorders BRENDON HOGAN, PHARMD PGY2 PSYCHIATRIC PHARMACY RESIDENT CTVHCS, TEMPLE, TX 09/23/2016 I would feel comfortable dispensing/prescribing
More informationEffects of Marijuana On Brain, Body & Behavior. Nora D. Volkow, M.D. Director
Effects of Marijuana On Brain, Body & Behavior Nora D. Volkow, M.D. Director Marijuana is the Most Commonly Used Illicit Drug In the U.S. Over 111 million Americans have tried it at least once An estimated
More informationE-Cigarette Use Transitions: a Case Study from Waves 1 & 2 of the PATH Study
March 2017 SRNT Pre-Conference Workshop: FDA s Population Health Standard: Balancing the Risks and Benefits in Regulatory Decision-Making E-Cigarette Use Transitions: a Case Study from Waves 1 & 2 of the
More informationBackground. Abstinence rates associated with varenicline
What are the range of abstinence rates for varenicline for smoking cessation? Do they differ based on treatment duration? Are there any studies utilizing 3-4 months of varenicline treatment? Background
More informationADHD & Addictions -What We Know
ADHD & Addictions -What We Know Dr. David Teplin, Psy.D., C.Psych. 4th CADDAC Annual Conference, Toronto October 14, 2012 1 Introduction Adult ADHD commonly co-exists with several other disorders, including
More information3. Chantix [package insert]. New York, NY: Pfizer, Inc,; Ramon JM, Morchon S, Baena A, Masuet-Aumatell C. Combining varenicline and nicotine
How can there be a warning regarding concomitant use of varenicline with nicotine replacement therapy yet patients can be on varenicline and smoke concurrently? April 20, 2017 The United States (US) Preventive
More informationUpdate on Medications for Tobacco Cessation
Update on Medications for Tobacco Cessation Marc Fishman MD Johns Hopkins University Dept of Psychiatry Maryland Treatment Centers Baltimore MD MDQuit Best Practices Conference Jan 2013 Nicotine Addiction
More informationCommunicating the Risk of Nicotine Delivery Products
Communicating the Risk of Nicotine Delivery Products August 10, 2014 ACS National Meeting Jim Solyst June 24, 2014 1 Nicotine Background Key Points The popularity of e-cigarettes has increased the need
More informationNebraska Youth Tobacco Survey 2015/2017
Nebraska Youth Tobacco Survey 2015/2017 TABLE OF CONTENTS Introduction... 1 Background... 1 Method... 1 Sampling Frame and Response Rates... 1 Weighting Data... 2 Terms and Definitions... 3 Executive Summary...
More informationTeen Mental Health and Substance Abuse. Cheryl Houtekamer AHS - AADAC Youth Services Calgary
Teen Mental Health and Substance Abuse Cheryl Houtekamer AHS - AADAC Youth Services Calgary Agenda Me? Talk about mental health?? Adolescent development Brain development Adolescent drug use Mental health
More informationDebunking Marijuana MythsON THE TEENAGE BRAIND
Debunking Marijuana MythsON THE TEENAGE BRAIND Harold C. Urschel III, MD, MMA March 7, 2018 All contents copyright 2018 Enterhealth LLC ADDICTION IS A SPECTRUM DISORDER Alcohol and drug use falls along
More informationSUBSTANCE USE DISORDER IN ADOLESCENT POPULATION
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences SUBSTANCE USE DISORDER IN ADOLESCENT POPULATION ANNABELLE SIMPSON, MD UNIVERSITY OF WASHINGTON GENERAL DISCLOSURES
More informationThe Latest on Vaping Among U.S. Teens
The Latest on Vaping Among U.S. Teens Jon Macy, PhD, MPH Indiana University School of Public Health Bloomington Presentation Outline Overview of Electronic Nicotine Delivery Systems (ENDS) New Prevalence
More informationAmber Bullock, MPH, CHES 12/10/12
CHALLENGES & EMERGING TRENDS IN TOBACCO HEALTH DISPARITIES: IMPLICATIONS FOR MENTAL HEALTH PROFESSIONALS Amber Bullock, MPH, CHES 12/10/12 WHAT IS LEGACY? Nonprofit public health foundation located in
More informationSmoking Cessation. Disclosures. Thank You. None
Smoking Cessation Dr. Jamie Kellar; BSc, BScPhm, PharmD Clinician Educator Centre for Addiction and Mental Health Assistant Professor Leslie Dan Faculty of Pharmacy Disclosures None Thank You Several slides
More informationImplicit Bias and Tobacco Cessation Services Increasing Impact through Understanding and Action
Implicit Bias and Tobacco Cessation Services Increasing Impact through Understanding and Action Thursday, August 31 st, 2017, 2:00pm EDT Presented by: Nicole Mueller, BA Mary Mancuso, MA Welcome! Margaret
More informationMARIJUANA: Selected Effects on Brain, Body & Behavior
MARIJUANA: Selected Effects on Brain, Body & Behavior February, 2012 Marijuana is the Most Commonly Used Illicit Drug In the U.S. Over 106 million Americans have tried it at.least once An estimated 2.4
More informationMood Disorders and Addictions: A shared biology?
Mood Disorders and Addictions: A shared biology? Dr. Paul Stokes Clinical Senior Lecturer, Centre for Affective Disorders, Department of Psychological Medicine Disclosures No relevant disclosures: No paid
More informationMarijuana: What Future Do You See?
Marijuana: What Future Do You See? Marijuana and Children s Mental Health - Why it Matters Speaker: Christian C. Thurstone, MD Activity Medical Director Celia Woods, MD Cheryl Lambing, MD, FAAFP, CME Director
More informationSmoking Cessation Strategies in 2017
Smoking Cessation Strategies in 2017 Robert Schilz DO, PhD, FCCP Division of Pulmonary, Critical Care and Sleep Medicine Director of Lug Transplantation University Hospitals of Cleveland Case Western University
More informationNIAAA: Current and Future Priorities. George F. Koob, Ph.D. Director National Institute on Alcohol Abuse and Alcoholism National Institutes of Health
NIAAA: Current and Future Priorities George F. Koob, Ph.D. Director National Institute on Alcohol Abuse and Alcoholism National Institutes of Health Cost and Scope of Addiction Alcohol Issues Across the
More informationDual Use: If Electronic Cigarettes are so good, why are there so few exclusive users?. Jonathan Foulds, PhD
Dual Use: If Electronic Cigarettes are so good, why are there so few exclusive users?. Jonathan Foulds, PhD jfoulds@psu.edu Penn State College of Medicine, Department of Public Health Science May 8, 2017
More informationTobacco-related risk perceptions in the regulation of tobacco products at the FDA Center for Tobacco Products
Tobacco-related risk perceptions in the regulation of tobacco products at the FDA Center for Tobacco Products David B. Portnoy, PhD, MPH Conrad J. Choiniere, PhD Office of Science FDA, Center for Tobacco
More informationnational institute on drug abuse national institutes of health Revised
national institute on drug abuse national institutes of health Revised Contents... What is marijuana? Are there different kinds? 2 How is marijuana used? 4 How long does marijuana stay in the user s body?
More informationTUPAC Five-Year Action Plan
TUPAC Five-Year Action Plan 2015-2020 New Mexico Department of Health Tobacco Use Prevention and Control Program 5301 Central Avenue NE, Suite 800, Albuquerque, NM 87108 505.841.5845 nmtupac.com TUPAC
More informationNicotine Reduction: Harm Reduction not Prohibition
Nicotine Reduction: Harm Reduction not Prohibition Eric C. Donny, Ph.D. Endowed Professor, Departments of Physiology & Pharmacology and Social Sciences & Health Policy Director, Center for the Evaluation
More informationYouth Tobacco Use in Massachusetts
Youth Tobacco Use in Massachusetts Survey Results from 1993 to 2011 The Commonwealth of Massachusetts Department of Public Health Department of Elementary and Secondary Education January 2013 Table of
More informationSWITCH Trial. A Sequential Multiple Adaptive Randomization Trial
SWITCH Trial A Sequential Multiple Adaptive Randomization Trial Background Cigarette Smoking (CDC Estimates) Morbidity Smoking caused diseases >16 million Americans (1 in 30) Mortality 480,000 deaths per
More informationProject ECHO Importance of Treating Tobacco Use In People With Behavioral Health Disorders Jan Blalock, Ph.D.
Project ECHO Importance of Treating Tobacco Use In People With Behavioral Health Disorders Jan Blalock, Ph.D. High Levels Of Tobacco Use Almost twice as likely to smoke as people without disorders (36.1%
More informationTobacco Treatment during Addictions Treatment or Recovery: A Review of the Literature
Tobacco Treatment during Addictions Treatment or Recovery: A Review of the Literature Judith J. Prochaska, PhD, MPH University of California, San Francisco Research supported by NIDA #P50-DA09253 and #K23-DA018691,
More informationTobacco & Mississippi Youth
Tobacco & Mississippi Youth Youth Tobacco Use Where we are now: 1998-2012 - Early current tobacco use decreases have leveled off in recent years - Why? Education & community activities Taxes & policies
More informationEffectively Addressing Co-Occurring Nicotine Dependence and Marijuana Use. Chad Morris, PhD March 7, 2018
Effectively Addressing Co-Occurring Nicotine Dependence and Marijuana Use Chad Morris, PhD March 7, 2018 2018 BHWP Behavioral Causes of Death in U.S. 2018 BHWP 2018 BHWP Health Disparities Population Behavioral
More informationTOBACCO TREATMENT INPATIENT QUALITY MEASURES. Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: December 2015
TOBACCO TREATMENT INPATIENT QUALITY MEASURES Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: December 2015 The Joint Commission has included a tobacco treatment measure set in their National Hospital
More information10/6/2015. Quotes from the Literature PATIENT, PROGRAM AND POLICY STRATEGIES TO REDUCE TOBACCO USE IN ADDICTION TREATMENT.
PATIENT, PROGRAM AND POLICY STRATEGIES TO REDUCE TOBACCO USE IN ADDICTION TREATMENT Joseph Guydish, PhD University of California, San Francisco National Conference on Tackling Tobacco Use in Vulnerable
More informationMarijuana. How is Marijuana Abused? How Does Marijuana Affect the Brain?
Marijuana Marijuana is the most commonly abused illicit drug in the United States. It is a dry, shredded green and brown mix of flowers, stems, seeds, and leaves derived from the hemp plant Cannabis sativa.
More informationA REPORT ON THE INCIDENCE AND PREVALENCE OF YOUTH TOBACCO USE IN DELAWARE
A REPORT ON THE INCIDENCE AND PREVALENCE OF YOUTH TOBACCO USE IN DELAWARE RESULTS FROM THE ADMINISTRATION OF THE DELAWARE YOUTH TOBACCO SURVEY IN SPRING 00 Delaware Health and Social Services Division
More informationEpidemiology of Hardcore Smoking: The Need to Advance the Field
Epidemiology of Hardcore Smoking: The Need to Advance the Field Gary A. Giovino, Ph.D Transdisciplinary Classification of Hardcore Smokers: How Shall We Define Hardcore? Symposium 10 th Annual Meeting
More informationTobacco Use and Cessation in Psychiatric Patients
Tobacco Use and Cessation in Psychiatric Patients John Spangler, MD, MPH Professor of Family Medicine Wake Forest School of Medicine NCPA, October 2015 Disclosure I have no relevant financial relationship
More information2015 South Carolina Profile on Alcohol, Tobacco, and Other Substance Related Indicators
21 South Carolina Profile on Alcohol, Tobacco, and Other Substance Related Indicators Prepared by South Carolina Department of Alcohol and Other Drug Abuse Services (DAODAS) State Epidemiological Outcomes
More informationTobacco Dependence: Assessment and Treatment. Douglas Arenberg
Tobacco Dependence: Assessment and Treatment Douglas Arenberg Disclosure MDCH Grant Funds to improve tobacco cessation service in the Michigan Medicine Health System Past paid service Consultant/Advisory
More informationBertha K Madras, PhD Professor of Psychobiology Department of Psychiatry Harvard Medical School McLean Hospital
Bertha K Madras, PhD Professor of Psychobiology Department of Psychiatry Harvard Medical School McLean Hospital bmadras@partners.org Users The Brain Adolescent Marijuana Safety Marijuana and Opioids Protecting
More informationWhat are long term effects of Marijuana use?
1 What are long term effects of Marijuana use? A. It is addictive B. It can alter the brain C. It can cause problems to your lungs and respiratory system D. All of the above Correct answer: All of the
More informationTreatment Team Approaches in Substance Abuse Treatment
Treatment Team Approaches in Substance Abuse Treatment PLANT A SEED AND WATCH IT GROW 2 Substance use disorders span a wide variety of problems arising from substance use, and cover 11 different criteria:
More informationADOLESCENT SUBSTANCE ABUSE & THE FAMILY
ADOLESCENT SUBSTANCE ABUSE & THE FAMILY KARA S. BAGOT, M.D. UNIVERSITY OF CALIFORNIA, SAN DIEGO OVERVIEW HBO ADDICTION -VIDEO EPIDEMIOLOGY OF ADOLESCENT SUBSTANCE USE ADOLESCENT NEURODEVELOPMENT COMORBID
More informationKevin Walton, Ph.D. Chief, Clinical Research Grants Branch Division of Therapeutics and Medical Consequences NIDA. No disclosures
Kevin Walton, Ph.D. Chief, Clinical Research Grants Branch Division of Therapeutics and Medical Consequences NIDA No disclosures NIDA Organizational Chart Office of Diversity & Health Disparities Office
More informationNIDA-Modified ASSIST Prescreen V1.0 1
NIDA-Modified ASSIST Prescreen V1.0 1 F Name:... Sex ( ) F ( ) M Age... Interviewer... Date.../.../... Introduction (Please read to patient) Hi, I m, nice to meet you. If it s okay with you, I d like to
More informationTOBACCO PRODUCT OR MEDICAL PRODUCT?
TOBACCO PRODUCT OR MEDICAL PRODUCT? Priscilla Callahan-Lyon, MD Deputy Director Division of Individual Health Science Office of Science, CTP Grail Sipes, JD Director Office of Regulatory Policy, CDER Disclaimer:
More informationEVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO
EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO Lena Matthias Gray, MSA, CTTS-M University of Michigan MHealthy Tobacco Consultation Service Overview of Tobacco Use The World Health Organization
More informationMarijuana and tobacco use among young adults in Canada: are they smoking what we think they are smoking?
DOI 10.1007/s10552-006-0103-x ORIGINAL PAPER Marijuana and tobacco use among young adults in Canada: are they smoking what we think they are smoking? Scott T. Leatherdale Æ David G. Hammond Æ Murray Kaiserman
More informationdependnece in comparison with Karl Fagerstrom Ph.D. Fagerstrom Consulting
Snus: Degree of harm and dependnece in comparison with other tobacco/nicotine ti products. Karl Fagerstrom Ph.D. Fagerstrom Consulting karl.fagerstrom@swipnet.se That humanity at large will ever be able
More informationWyoming Quit Tobacco Program Follow-Up Survey
October 5, 2016 Wyoming Quit Tobacco Program Follow-Up Survey January June 2016 Interviews Muneyuki Kato, MA, Assistant Research Scientist Tiffany Comer Cook, MS, Senior Research Scientist Laran H. Despain,
More informationTobacco Surveillance in the United States
Tobacco Surveillance in the United States Gary Giovino Roswell Park Cancer Institute National Conference on Tobacco OR Health San Francisco, California November 20, 2002 Outline of Presentation Public
More informationTony Klein, MPA, CASAC, NCACII
Tony Klein, MPA, CASAC, NCACII Presentation Overview Tobacco Dependence in Individuals with Co-occurring Addictions Challenges and Barriers Organizational Change Strategies Program & System Changes to
More informationFDA s Action Agenda to Reduce Tobacco Related-Cancer Incidence and Mortality
FDA s Action Agenda to Reduce Tobacco Related-Cancer Incidence and Mortality Lawrence Deyton, M.S.P.H., M.D. Director, FDA Center for Tobacco Products June 11, 2012 FDA s Vision To make tobaccorelated
More informationRADM Patrick O Carroll, MD, MPH Senior Advisor, Assistant Secretary for Health, US DHSS
Ending the Tobacco Epidemic RADM Patrick O Carroll, MD, MPH Senior Advisor, Assistant Secretary for Health, US DHSS Tim McAfee, MD, MPH Senior Medical Officer, Office on Smoking and Health, CDC www.nwcphp.org/hot-topics
More informationScience = Solutions For Substance Use Disorders and Infant Outcomes. Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse
Science = Solutions For Substance Use Disorders and Infant Outcomes Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse Science = Solutions Increased Opioid Mortality: Greater
More informationADHD and Substance Use Disorders: An Intoxicating Combination
ADHD and Substance Use Disorders: An Intoxicating Combination Timothy E. Wilens, MD Chief, Division of Child & Adolescent Psychiatry Director, Center for Addiction Medicine Massachusetts General Hospital
More informationUpdates in the Treatment of Tobacco Use Disorder
Updates in the Treatment of Tobacco Use Disorder Jill M Williams, MD Professor Psychiatry Director, Division Addiction Psychiatry Robert Wood Johnson Medical School Disclosures Grant Support from Pfizer
More informationNIDA-Modified ASSIST - Prescreen V1.0*
NIDA-Modified ASSIST Assessment Instrument [1] NIDA-Modified ASSIST - Prescreen V1.0* *This screening tool was adapted from the WHO Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) Version
More informationPharmacotherapy for Tobacco Dependence Treatment
Pharmacotherapy for Tobacco Dependence Treatment Nancy Rigotti, MD Professor of Medicine, Harvard Medical School Director, Tobacco Research and Treatment Center, Massachusetts General Hospital nrigotti@partners.org
More informationLearning outcomes: Keeping it Real and Safe: What Every School Counselor Should Know About Underage Drinking
Keeping it Real and Safe: What Every School Counselor Should Know About Underage Drinking Aaron White, PhD - NIAAA April 18, 2018 Learning outcomes: Current trends in underage drinking How does alcohol
More informationMenthol cigarettes are a public health problem
Menthol cigarettes are a public health problem ANDREA VILLANTI, PHD MPH JUNE 22, 2016 disclosures Andrea Director The Adjunct Department Johns Villanti, PhD, MPH, CHES for Regulatory Science and Policy
More informationYouth Survey S Project y Project Sample State Bach
Sample State Bach Harrison Youth Survey Project Sample State Bach Harrison S Y Youth Su Youth Survey Project Sampl State Ba le State Bach Harrison Youth Survey Pro Bach H Sample Stat Bach Harrison Youth
More informationTobacco Treatment Measures KATHY WONDERLY RN, MSED, CPHQ CONSULTANT DEVELOPED: JANUARY 2018
Tobacco Treatment Measures KATHY WONDERLY RN, MSED, CPHQ CONSULTANT DEVELOPED: JANUARY 2018 Background This measure set is required for The Joint Commission participating hospitals only. Tobacco use is
More informationUPDATE ON PREMARKET TOBACCO PRODUCT AUTHORIZATION PATHWAY
UPDATE ON PREMARKET TOBACCO PRODUCT AUTHORIZATION PATHWAY Presented by Ii-Lun Chen, M.D Director Division of Individual Health Science Office of Science, CTP, FDA Disclaimer: This is not a formal dissemination
More informationTreatment of Tobacco and Cocaine Use Disorders
Treatment of Tobacco and Cocaine Use Disorders A. Eden Evins, MD, MPH Director, Center for Addiction Medicine Massachusetts General Hospital Associate Professor of Psychiatry Harvard Medical School A.
More informationClearing The Air about: Gretchen Hagenbuch, M.Ed. SAP Coordinator Philadelphia Region
Clearing The Air about: Gretchen Hagenbuch, M.Ed. SAP Coordinator Philadelphia Region Caron Quick Facts Nationally recognized behavioral healthcare and addiction treatment facility Addiction treatment
More informationTobacco Cessation for Women of Reproductive Age. Erin McClain, MA, MPH
Tobacco Cessation for Women of Reproductive Age Erin McClain, MA, MPH Tobacco Use During Pregnancy in NC 2 1 in 10 babies in NC are born to women reporting tobacco use during pregnancy In some counties
More information